Rezolute RZLT
NASDAQ RZLT
$3.70 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Rezolute (RZLT) Convertible Debt (2011 - 2018)

Updated

Rezolute (RZLT) reported Convertible Debt of $5.01 million for fiscal Q2 2019 (quarter ended Dec 31, 2018), up 3.4% from the prior quarter.

Analysis

Rezolute (RZLT) Convertible Debt (2011 - 2018) Analysis & Trends

At the end of FY2011 (ended Dec 31, 2011), Rezolute posted Convertible Debt of $54,958.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Rezolute 384.46 Mn -128.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 5.01 Mn
Sep 30, 2018 4.84 Mn
Dec 31, 2013 2.70 Mn
Mar 31, 2013 3.73 Mn
Dec 31, 2011 54,958.00
API Access

Rezolute Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=RZLT&period=max&api_key=YOUR_API_KEY